Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Acta Biochimica Polonica|April 30, 2017
Aliskiren reduces albuminuria after kidney transplantationLeszek Tylicki, Alicja M Debska-Slizien, Slawomir Lizakowski, et al.Transplantation Proceedings|March 29, 2022
Short-term Effects of Losartan on Cardiovascular Risk and Allograft Injury Biomarkers in Kidney Transplant RecipientsIzabella Kuźmiuk-Glembin, Zbigniew Heleniak, Renata Pięta, et al.Advances in Medical Sciences|August 9, 2014
Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over studyMarcin Renke, Sławomir Lizakowski, Leszek Tylicki, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 27, 2025
Lipid-lowering agents in solid organ transplant recipientsAgnieszka Mickiewicz, Sławomir Żegleń, Karolina Kędzierska-Kapuza, et al.Frontiers in Oncology|October 27, 2025
Prevalence of skin cancers in kidney transplant recipients - one-center experienceFabian Kosko, Alicja Dębska-Ślizień, Beata Imko-Walczuk, et al.Frontiers in Oncology|July 29, 2025
Retrospective assessment of the frequency of cancer in the population of kidney transplant recipients - the experience of two transplant centersKarolina Komorowska-Jagielska, Alicja Dębska-Ślizień, Aureliusz Kolonko, et al.European Journal of Internal Medicine|September 2, 2022
Physicians' responsibility toward environmental degradation and climate change: A position paper of the European Federation of Internal MedicineLuís Campos, J Vasco Barreto, Stefano Bassetti, et al.Nature Genetics|June 19, 2023
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathyKrzysztof Kiryluk, Elena Sanchez-Rodriguez, Xu-Jie Zhou, et al.Pageof 5